193 related articles for article (PubMed ID: 34731023)
1. Cisplatin Chemotherapy and Cochlear Damage: Otoprotective and Chemosensitization Properties of Polyphenols.
Fetoni AR; Paciello F; Troiani D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1229-1245. PubMed ID: 34731023
[No Abstract] [Full Text] [Related]
2. The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity.
Paciello F; Fetoni AR; Mezzogori D; Rolesi R; Di Pino A; Paludetti G; Grassi C; Troiani D
Sci Rep; 2020 Jan; 10(1):1063. PubMed ID: 31974389
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling.
Fetoni AR; Paciello F; Mezzogori D; Rolesi R; Eramo SL; Paludetti G; Troiani D
Br J Cancer; 2015 Nov; 113(10):1434-44. PubMed ID: 26469832
[TBL] [Abstract][Full Text] [Related]
6. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
7. Hesperidin activates Nrf2 to protect cochlear hair cells from cisplatin-induced damage.
Lou J; Wu F; He W; Hu R; Cai Z; Chen G; Zhao W; Zhang Z; Si Y
Redox Rep; 2024 Dec; 29(1):2341470. PubMed ID: 38629504
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
[TBL] [Abstract][Full Text] [Related]
9. Otoprotective Effects of Fucoidan Reduce Cisplatin-Induced Ototoxicity in Mouse Cochlear UB/OC-2 Cells.
Hsieh CY; Lin JN; Kang TY; Wen YH; Yu SH; Wu CC; Wu HP
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834972
[TBL] [Abstract][Full Text] [Related]
10. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
11. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo.
Hu B; Liu Y; Chen X; Zhao J; Han J; Dong H; Zheng Q; Nie G
Biochem Biophys Res Commun; 2020 Dec; 533(4):1442-1448. PubMed ID: 33109343
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cisplatin ototoxicity and progress in otoprotection.
Rybak LP
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):364-9. PubMed ID: 17823555
[TBL] [Abstract][Full Text] [Related]
13. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention.
Rybak LP; Mukherjea D; Ramkumar V
Semin Hear; 2019 May; 40(2):197-204. PubMed ID: 31036996
[TBL] [Abstract][Full Text] [Related]
15. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy.
Benkafadar N; Menardo J; Bourien J; Nouvian R; François F; Decaudin D; Maiorano D; Puel JL; Wang J
EMBO Mol Med; 2017 Jan; 9(1):7-26. PubMed ID: 27794029
[TBL] [Abstract][Full Text] [Related]
16. Emerging and established therapies for chemotherapy-induced ototoxicity.
Guthrie OW; Spankovich C
J Cancer Surviv; 2023 Feb; 17(1):17-26. PubMed ID: 36637631
[TBL] [Abstract][Full Text] [Related]
17. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
18. Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4.
Fritzsche S; Strauss C; Scheller C; Leisz S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628594
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.
Sheth S; Mukherjea D; Rybak LP; Ramkumar V
Front Cell Neurosci; 2017; 11():338. PubMed ID: 29163050
[TBL] [Abstract][Full Text] [Related]
20. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
